J Korean Med Assoc.  2014 Oct;57(10):826-831. 10.5124/jkma.2014.57.10.826.

Preoperative management of chronic disease

• Han HJ

• KMID: 1958381
• DOI: http://doi.org/10.5124/jkma.2014.57.10.826

Abstract

With the innovation and improvements in medical science, longer life expectancy has been achieved and growing population is being diagnosed and treated as chronic diseases such as diabetes, chronic pulmonary obstructive disease or hypertension. These chronic diseases often affect multiple organs of cardiovascular and neuroendocrine system and blunt regulatory function which is crucial for the defense response against external and internal harmful stresses. The risk of perioperative complications including cardiovascular events is also higher in poorly controlled diabetes or hypertension. Therefore it is very important to evaluate and manage these problems preoperatively. This paper reviews preoperative management of common chronic diseases such as diabetes, hypertension, and chronic pulmonary obstructive disease.

Keyword

Preoperative care; Chronic disease; Diabetes mellitus; Hypertension

MeSH Terms

Chronic Disease*
Diabetes Mellitus
Hypertension
Life Expectancy
Neurosecretory Systems
Preoperative Care

Reference

1. Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, Li C, Williams DE, Gregg EW, Bainbridge KE, Saydah SH, Geiss LS. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care. 2009; 32:287–294.

2. The Carter Center of Emory University. Closing the gap: the problem of diabetes mellitus in the United States. Diabetes Care. 1985; 8:391–406.

3. Kitamura A, Hoshino T, Kon T, Ogawa R. Patients with diabetic neuropathy are at risk of a greater intraoperative reduction in core temperature. Anesthesiology. 2000; 92:1311–1318.

4. Tsueda K, Huang KC, Dumont SW, Wieman TJ, Thomas MH, Heine MF. Cardiac sympathetic tone in anaesthetized diabetics. Can J Anaesth. 1991; 38:20–23.

5. Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham study. JAMA. 1979; 241:2035–2038.

6. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998; 339:229–234.

7. Madsen H, Ditzel J. Changes in red blood cell oxygen transport in diabetic pregnancy. Am J Obstet Gynecol. 1982; 143:421–424.

8. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008; 359:1577–1589.

9. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005; 353:2643–2653.

10. Schade DS. Surgery and diabetes. Med Clin North Am. 1988; 72:1531–1543.

11. Gavin LA. Management of diabetes mellitus during surgery. West J Med. 1989; 151:525–529.

12. Reissell E, Orko R, Maunuksela EL, Lindgren L. Predictability of difficult laryngoscopy in patients with long-term diabetes mellitus. Anaesthesia. 1990; 45:1024–1027.

13. Hogan K, Rusy D, Springman SR. Difficult laryngoscopy and diabetes mellitus. Anesth Analg. 1988; 67:1162–1165.

14. McEvoy GK. American Society of Health-System Pharmacists. American Hospital Formulary Service: miscellaneous anti-diabetic agents. Bethesda: American Society of Hospital Pharmacists;2000.

15. Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, Inzucchi SE, Ismail-Beigi F, Kirkman MS, Umpierrez GE. American Association of Clinical Endocrinologists. American Diabetes Association. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract. 2009; 15:353–369.

16. Sheehy AM, Gabbay RA. An overview of preoperative glucose evaluation, management, and perioperative impact. J Diabetes Sci Technol. 2009; 3:1261–1269.

17. Watson BG, Pay DA, Williamson M, Elliott MJ. Practical closed-loop insulin infusion. Life Support Syst. 1985; 3:Suppl 1. 519–523.

18. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW. American College of Cardiology. American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). American Society of Echocardiography. American Society of Nuclear Cardiology. Heart Rhythm Society. Society of Cardiovascular Anesthesiologists. Society for Cardiovascular Angiography and Interventions. Society for Vascular Medicine and Biology. Society for Vascular Surgery. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Periope-rative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol. 2007; 50:e159–e241.

19. Howell SJ, Sear JW, Foex P. Hypertension, hypertensive heart disease and perioperative cardiac risk. Br J Anaesth. 2004; 92:570–583.

20. Varon J, Marik PE. Perioperative hypertension management. Vasc Health Risk Manag. 2008; 4:615–627.

21. POISE Study Group. Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC, Xavier D, Chrolavicius S, Greenspan L, Pogue J, Pais P, Liu L, Xu S, Malaga G, Avezum A, Chan M, Montori VM, Jacka M, Choi P. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008; 371:1839–1847.

22. Wong DH, Weber EC, Schell MJ, Wong AB, Anderson CT, Barker SJ. Factors associated with postoperative pulmonary complications in patients with severe chronic obstructive pulmonary disease. Anesth Analg. 1995; 80:276–284.

23. McAlister FA, Bertsch K, Man J, Bradley J, Jacka M. Incidence of and risk factors for pulmonary complications after nonthoracic surgery. Am J Respir Crit Care Med. 2005; 171:514–517.

24. American Society of Anesthesiologists. ASA physical status classification system [Internet]. Schaumburg: American Society of Anesthesiologists;2014. cited 2014 Jun 5. Available from: https://www.asahq.org/clinical/physicalstatus.htm.

25. Arozullah AM, Daley J, Henderson WG, Khuri SF. Multifactorial risk index for predicting postoperative respiratory failure in men after major noncardiac surgery. The National Veterans Administration Surgical Quality Improvement Program. Ann Surg. 2000; 232:242–253.

26. De Nino LA, Lawrence VA, Averyt EC, Hilsenbeck SG, Dhanda R, Page CP. Preoperative spirometry and laparotomy: blowing away dollars. Chest. 1997; 111:1536–1541.

27. Ballantyne JC, Carr DB, deFerranti S, Suarez T, Lau J, Chalmers TC, Angelillo IF, Mosteller F. The comparative effects of postoperative analgesic therapies on pulmonary outcome: cumulative meta-analyses of randomized, controlled trials. Anesth Analg. 1998; 86:598–612.